ruthenium-tris(pyrazolyl)methane complexes as potential candidates for cancer chemotherapy agents
| dc.contributor.advisor | spivak, gregory | |
| dc.contributor.advisor | gottardo, christine | |
| dc.contributor.author | walker, jesse morgan | |
| dc.date.accessioned | 2012-11-11t00:59:51z | |
| dc.date.available | 2012-11-11t00:59:51z | |
| dc.date.created | 2009 | |
| dc.date.issued | 2009 | |
| dc.identifier.uri | http://knowledgecommons.lakeheadu.ca/handle/2453/218 | |
| dc.description.abstract | the mecn ligands of complex 1 were substitutionally inert, however, under forcing conditions the dmso ligands of complex 2 were displaced by chelating 1,2-bis(diphenylphosphino)ethane to produce complex 6. structural characterization of compounds 1-8 was performed by nmr spectroscopy, and an x-ray diffraction analysis of complex 7 provided additional evidence for the proposed structures. | en_us |
| dc.language.iso | en_us | en_us |
| dc.subject | antineoplastic agents | en_us |
| dc.subject | ruthenium compounds | en_us |
| dc.subject | organoruthenium compounds | en_us |
| dc.subject | organometallic chemistry | en_us |
| dc.subject | organometallic compounds | en_us |
| dc.subject | cancer | en_us |
| dc.subject | chemotherapy | en_us |
| dc.subject | research | en_us |
| dc.title | ruthenium-tris(pyrazolyl)methane complexes as potential candidates for cancer chemotherapy agents | en_us |
| dc.type | thesis | en_us |
| etd.degree.name | master of science | |
| etd.degree.level | master | en_us |
| etd.degree.discipline | chemistry | en_us |
| etd.degree.grantor | 阿根廷vs墨西哥竞猜 | en_us |
